\
&
Contact us
\
&
Contact us
This was 9 months ago
LocationZeebrugge, Belgium
ProgrammesThe Belgian Navy Hackathon is an Open Innovation event. It brings together Navy personnel and civilian professionals, representing the entire Belgian maritime ecosystem.
On September 24 and 25, participants will work in small, multidisciplinary groups to imagine, develop, and pitch projects for solving concrete, urgent challenges identified jointly by the Navy and the maritime ecosystem.
Winning projects will be presented during Captains of Industry Day at TECHNOFest 2024 on October 4.
Four challenges for this hackathon have been identified by the Navy staff and validated by representatives of the maritime ecosystem in four workshops.
Solving these hard challenges will take the knowledge and experience of dozens of people, and of course your fresh perspective, your ingenuity, and your ability to think creatively and strategically.
Anti-drone measures
Public Awareness for Accelerating Recruitment
Resilience of the Logistical Infrastructure
More information and registration: https://inno4def.be/nh24/
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
